Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas

• Hauptverfasser: Evelin Makk (Verfasst von), Noémi Bohonyi (Verfasst von), Angéla Oszter (Verfasst von), Klára Éles (Verfasst von), Tamás Tornóczky (Verfasst von), Arnold Tóth (Verfasst von), Endre Kálmán (Verfasst von), Krisztina Kovács (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Introduction: The role of p16 and p53 immunohistochemistry in the diagnosis of rare and aggressive uterine carcinosarcoma (UCS) has been well established. However, enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a member of the polycomb group family is a relatively new biomarker,...